Kava and valerian in the treatment of stress-induced insomnia.
Study Design
- Type d'étude
- Controlled Clinical Trial
- Taille de l'échantillon
- 24
- Population
- Patients with stress-induced insomnia
- Durée
- 12 weeks
- Intervention
- Kava and valerian in the treatment of stress-induced insomnia. Kava 120mg/day (6 wks), then valerian 600mg/day (6 wks)
- Comparateur
- Baseline comparison
- Critère de jugement principal
- Stress, insomnia, social functioning
- Direction de l'effet
- Positive
- Risque de biais
- High
Abstract
Kava and valerian are herbal remedies, claimed to have anxiolytic and sedative properties respectively, without dependence potential or any appreciable side-effects. In this pilot study, 24 patients suffering from stress-induced insomnia were treated for 6 weeks with kava 120 mg daily. This was followed by 2 weeks off treatment and then, 5 having dropped out, 19 received valerian 600 mg daily for another 6 weeks. Stress was measured in three areas: social, personal and life-events; insomnia in three areas also: time to fall asleep, hours slept and waking mood. Total stress severity was significantly relieved by both compounds (p < 0.01) with no significant differences between them; as was also insomnia (p < 0.01). The proportion of patients with no side-effects was 58% with each drug respectively and the 'commonest' effect was vivid dreams with valerian (16%), followed by dizziness with kava (12% ). These compounds may be useful in the treatment of stress and insomnia but further studies are required to determine their relative roles for such indications.
En bref
These compounds may be useful in the treatment of stress and insomnia but further studies are required to determine their relative roles for such indications.
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
The American journal of medicine · 2006
Valerian for sleep: a systematic review and meta-analysis.
Clinical therapeutics · 2016
Review of Safety and Efficacy of Sleep Medicines in Older Adults.
Sleep medicine reviews · 2011
A systematic review of insomnia and complementary medicine.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 1999
Unsafe and potentially safe herbal therapies.
Sleep medicine · 2000